<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160307026950N35</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-06</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Dexmedetomidine on nausea and vomiting in Discectomy surgery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of two different doses of Dexmedetomidine on the prevention of nausea and vomiting in Discectomy under spinal anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>135</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57151</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: This is a simple randomized clinical trial in which individuals enter study groups by lottery; The drugs and placebo are placed in the desired number in sealed opaque and uniform sealed envelopes. Each of the codes is also 
written on a piece of paper, folded and placed inside a box. After entering the operating room, each patient takes one of the papers out of the box. Which is applied to the patient. This continues until the end of the paperwork so that the number of patients in the desired volume in the groups, Blinding description: This was a double-blind controlled clinical trial in which the patient and the evaluator had no known information about the type and dose of the drug.</study_design>
      <phase>3</phase>
      <hc_freetext>Nausea and vomiting due to Discectomy under spinal anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group D1: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia and dexmedetomidine injection, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then 0.2 micrograms per kilogram of body weight per hour Dexmedetomidine made in Germany, which was increased to 10cc by normal saline, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery. Intervention 2: Intervention group D2: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia and dexmedetomidine injection, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then 0.5 micrograms per kilogram of body weight per hour Dexmedetomidine made in Germany, which was increased to 10cc by normal saline, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery. Intervention 3: Control group C: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then, 10cc of normal saline made by Saha Med Company, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Negar Khan ahmad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8146713543</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>behzad_nazem@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behzad Nazem roaya</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8146713543</zip>
        <telephone>+98 31 3620 2020</telephone>
        <email>behzad_nazem@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients 18 to 60 years
Candidate for Discectomy under spinal anesthesia
Grade 1 and 2 Anesthesia Based on American Society Anesthesia Criteria</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of cardiovascular, respiratory, neurological, endocrine, thyroid, neuromuscular diseases, dysautonomia
Fever
Obesity (BMI&gt; 27)
History of vasoactive drugs, MAOI and TCA
History of drug use
Allergy to Pethidine, Ketamine and Magnesium sulfate
Pregnancy
Allergy to Dexmedetomidine
Taking drugs with drug interactions with Dexmedetomidine</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group D1: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia and dexmedetomidine injection, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then 0.2 micrograms per kilogram of body weight per hour Dexmedetomidine made in Germany, which was increased to 10cc by normal saline, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery.</i_keyword>
      <i_keyword>Intervention group D2: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia and dexmedetomidine injection, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then 0.5 micrograms per kilogram of body weight per hour Dexmedetomidine made in Germany, which was increased to 10cc by normal saline, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery.</i_keyword>
      <i_keyword>Control group C: From the time of entering the operating room until before spinal anesthesia, 500cc of Ringer's lactate serum made in Iran was administered intravenously to patients. After entering the operating room, before spinal anesthesia, blood pressure (by non-invasive sphygmomanometer), arterial oxygen saturation (SpO2) were measured by pulse oximetry and baseline vital signs. Then, 10cc of normal saline made by Saha Med Company, after spinal anesthesia and placing the patient in the desired position, was received as an intravenous infusion pump for 10 minutes. After that, the patient's vital signs were measured and recorded again until the end of surgery and then in recovery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nausea and vomiting due to dexmedetomidine injection. Timepoint: Immediately after spinal up to 24 hours after surgery. Method of measurement: Use Visual Analogue Scale or VAS.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart Rate. Timepoint: Immediately after spinal up to 24 hours after surgery. Method of measurement: ECG monitoring.</sec_outcome>
      <sec_outcome>Systolic blood pressure. Timepoint: Immediately after spinal up to 24 hours after surgery. Method of measurement: Barometer.</sec_outcome>
      <sec_outcome>Diastolic blood pressure. Timepoint: Immediately after spinal up to 24 hours after surgery. Method of measurement: Barometer.</sec_outcome>
      <sec_outcome>Arterial blood oxygen saturation. Timepoint: Immediately after spinal up to 24 hours after surgery. Method of measurement: Pulse oximeter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-24</approval_date>
        <contact_name>Ethics Committee in Biomedical Research, Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezar Jarib St Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
